Gas6-Mer轴在内皮功能障碍中起关键作用,促进GVHD相关TA-TMA
本研究探讨Gas6-Mer轴在造血干细胞移植后GVHD相关TA-TMA内皮功能障碍中的作用。发现HSCT合并II-IV级aGVHD患者血清Gas6显著升高,且与LDH、D-二聚体等升高相关;体外实验显示Gas6或III级aGVHD血清可诱导内皮细胞血栓调节蛋白下调和PAI-1上调,Mer抑制剂UNC2250可逆转;小鼠模型中UNC2250可显著抑制GVHD和TA-TMA。提示Gas6-Mer轴是GVHD后TA-TMA的潜在靶点。
要点
- HSCT合并II-IV级aGVHD患者血清Gas6水平显著升高,并与LDH、D-二聚体、纤溶酶抑制物复合物升高相关。
- aGVHD患者大肠和皮肤病灶中Gas6与Mer表达上调。
- Mer抑制剂UNC2250可逆转Gas6诱导的内皮细胞TM下调和PAI-1上调,并抑制小鼠GVHD和TA-TMA。
核心结论
- Gas6-Mer轴在内皮功能障碍中起关键作用,促进GVHD相关TA-TMA,是潜在治疗靶点。
研究设计与样本
- 研究纳入HSCT患者分析血清Gas6水平及aGVHD病灶表达,并用人脐静脉内皮细胞体外实验和小鼠HSCT模型验证。
主要发现
- HSCT合并II-IV级aGVHD患者血清Gas6水平显著升高,且与LDH、D-二聚体、纤溶酶抑制物复合物升高相关。
- aGVHD患者大肠和皮肤病灶中Gas6和Mer表达上调。
- 体外实验中,外源性Gas6或III级aGVHD患者血清处理内皮细胞可诱导血栓调节蛋白下调和PAI-1上调,并上调ICAM-1和VCAM-1,UNC2250可抑制这些效应。
- 小鼠HSCT模型中出现肝脏GVHD(肝细胞凋亡、坏死、纤维化)及TA-TMA(肝和肾微血管血栓形成),静脉给予UNC2250可显著抑制GVHD和TA-TMA。
临床怎么用
- Gas6-Mer轴可能作为GVHD后TA-TMA的潜在治疗靶点,但尚未进入临床实践。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endothelial dysfunction in the early phases of hematopoietic stem cell transplantation (HSCT) contributes to a common pathology between transplant-associated thrombotic microangiopathy (TA-TMA) and graft-versus-host disease (GVHD), which are serious complications of HSCT. Growth arrest-specific (Gas) 6 structurally belongs to the family of plasma vitamin K-dependent proteins working as a cofactor for activated protein C, and has growth factor-like properties through its interaction with receptor tyrosine kinases of the TAM family: Tyro3, Axl, and Mer. Serum Gas6 levels were significantly increased in HSCT patients with grade II to IV acute GVHD (aGVHD), and Gas6 and Mer expression levels were upregulated in aGVHD lesions of the large intestine and skin. The increased serum Gas6 levels were also correlated with elevated lactate dehydrogenase, d-dimer, and plasmin inhibitor complex values in HSCT patients with aGVHD. In human umbilical vein endothelial cells (ECs), exogenous Gas6 or the exposure of sera isolated from patients with grade III aGVHD to ECs induced the downregulation of thrombomodulin and the upregulation of PAI-1, as well as the upregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, which were inhibited by UNC2250, a selective Mer tyrosine kinase inhibitor. In mouse HSCT models, we observed hepatic GVHD with hepatocellular apoptosis, necrosis, and fibrosis, as well as TA-TMA, which is characterized pathologically by thrombosis formation in the microvasculature of the liver and kidney. Of note, intravenous administration of UNC2250 markedly suppressed GVHD and TA-TMA in these mouse HSCT models. Our findings suggest that the Gas6-Mer axis is a promising target for TA-TMA after GVHD.
引用
- Furukawa M, Wang X, Ohkawara H, et al. A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD. Blood Adv. 2019. PMID: 31300420. doi:10.1182/bloodadvances.2019000222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。